Monthly Archives: May 2018

sphingotec is adding an advanced POC testing platform to portfolio

sphingotec is adding an advanced POC testing platform to portfolio sphingotec GmbH will offer its next-generation sepsis, heart failure and acute kidney injury biomarkers penKid® and bio-ADM® on NEXUS IB 10 point-of-care (POC) testing platform, originally developed by Nexus Dx   penKid® and bio-ADM® are first-in-class biomarkers to diagnose and monitor real-time kidney function and…
Read more

Cookie Preference

Please select an option. You can find more information about the consequences of your choice at Help. Privacy Policy | Imprint

Select an option to continue

Your selection was saved!

More information

Help

To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.

  • Accept all cookies:
    All cookies such as tracking and analytics cookies.
  • Accept first-party cookies only:
    Only cookies from this website.
  • Reject all cookies:
    No cookies except for those necessary for technical reasons are set. Borlabs Cookie already set a necessary cookie.

You can change your cookie setting here anytime: Privacy Policy. Imprint

Back

Top